Sensodyne, Panadol, Voltaren, Centrum, Advil, Polident, Otrivin and Parodontax separated from GSK
GSK demerged its consumer healthcare business as Haleon, listing it in London and New York in July 2022. The business already contained Pfizer's consumer health portfolio, contributed to a joint venture in 2019, which is how Advil and Centrum came to sit alongside Sensodyne and Panadol.